European Cancer Congress | Conference

Chemo During Pregnancy Did Not Affect Early Child Development
October 02, 2015

Children exposed to their mother’s cancer and cancer treatment did not appear to have cardiac, cognitive, or general developmental issues up to 36 months of age.

Some Breast Cancer Patients Can Forgo Chemotherapy
October 01, 2015

Some patients with early-stage HR-positive breast cancer can be treated with hormone therapy alone, avoiding chemo without increasing their recurrence risk.

Colorectal Tumors Differ By Age
September 30, 2015

A study showed that tumors of younger patients with early-onset colorectal cancer differ from the tumors of those diagnosed later in life, both genetically and epigenetically.

RADIANT-4: Everolimus Effective in Lung, GI NETs
September 29, 2015

Nonfunctional neuroendocrine tumors of lung or gastrointestinal origin were safely and effectively treated with the mTOR inhibitor everolimus.

Genetics of Brain Metastases Reveal Potential Drug Targets
September 28, 2015

A genomic analysis of the primary tumors and brain metastases of patients has revealed potentially targetable mutations only present in the brain metastases.

Lutathera Delayed Progression of Midgut Neuroendocrine Tumors
September 28, 2015

Patients with midgut neuroendocrine tumors had significantly delayed disease progression when treated with Lutathera compared with the current standard of care.

Surgery May Be Best Treatment for Advanced Head and Neck Cancers
September 27, 2015

Undergoing primary surgery may be the best treatment option for patients with advanced oropharyngeal and hypopharyngeal cancers.

METEOR: Cabozantinib Improves Survival in Advanced Kidney Cancer
September 26, 2015

Cabozantinib significantly delayed progression of disease compared with everolimus in patients with advanced clear cell renal cell carcinoma.

EUROCARE-5: Blood Cancer Survival Rates Vary Greatly Across Europe
September 25, 2015

Data taken from EUROCARE showed large variations in survival rates from several hematologic malignancies across European countries, with lower survival in Eastern Europe and higher survival in Northern and Central Europe.

HPV Vaccines Continue to Improve, But More Uptake Required
September 24, 2015

In this interview we discuss the latest on HPV vaccines for cancer prevention and some of the struggles countries face in achieving widespread adoption.